Correspondence: Ruggero Dittadi, Department of Laboratory Medicine, Laboratory Analysis Unit, Regional General Hospital, ULSS12 Veneziana,
Via Paccagnella 11, 30174 Mestre-Venice, Italy. Tel: +39 41965 8216. Fax: +39 4196 57557. E-mail: ruggero.dittadi@ulss12.ve.it
(Received 2 February 2013; accepted 13 May 2013)
ORIGINAL ARTICLE
Evaluation of a sex hormone-binding globulin automated
chemiluminescent assay
RUGGERO DITTADI
1
, ALINE S. C. FABRICIO
2
, SILVIA MICHILIN
2
& MASSIMO GION
1
1
Laboratory Analysis Unit and
2
Regional Center for Biomarkers, Department of Laboratory Medicine,
Regional General Hospital,Venice, Italy
Abstract
Background. Sex hormone-binding globulin (SHBG) is the main transport protein of sex steroids. This study evaluated
the analytical performance of the recently developed Access SHBG assay (Beckman Coulter) and compared it with other
commercial methods for the determination of serum SHBG. Clinical validation was also performed. Methods. Analytical
performance including within-run and between-run imprecision was assessed for Access SHBG assay on the automated
Beckman UniCel DxI800 analyzer. Linearity was assessed using five dilutions of the serum samples. For methods com-
parison, SHBG levels were determined also with Immulite 2000 analyzer (Siemens Healthcare) using clinical serum sam-
ples ( n = 104). For clinical validation 135 specimens from healthy subjects, pregnant women, hypothyroid and hyperthyroid
patients were analyzed. Results. Total coefficients of variation were 5.5%. Linearity test showed 90% recovery for all
samples and for all dilution rates. Comparison analysis (Bland-Altman difference analysis and Passing-Bablock regression)
showed an acceptable agreement between selected methods. SHBG values measured by Access SHBG assay in different
groups of subjects were in agreement with other clinical evidence. Conclusions. Automated Access SHBG assay appears
to be a reliable and easy to perform assay, as necessary for application in routine diagnostics.
Key Words: Immunoassay , SHBG, method comparison, free Testosterone, method validation
Introduction
Sex hormone-binding globulin (SHBG) is an 86 kDa
circulating beta globulin synthesized in the liver [1]
that transports and regulates the access of sex ste-
roids from blood to their target tissues [2]. SHBG
levels in healthy subjects are related to several
variables such as diet, body mass index, insulin
concentrations, age and circulating estrogens [3–5].
Furthermore, in some cases, it has been shown that
SHBG is an independent predictor factor of bone
mineral density [6]. Moreover, the measurement of
SHBG can be an important indicator of chronic or
excessive androgenic activity. In fact, decreased
levels of SHBG are often observed in cases with hir-
sutism, obesity and polycystic ovarian syndrome
[7,8]. SHBG measurement, as recommended by
The Endocrine Society [9] is also used to calculate
index of bioactive fractions of testosterone, the cal-
culated free testosterone (FT) and the bioavailable
testosterone (bioT) [10].
With the final aim to use the test for routine
diagnostic application, this study was undertaken to
evaluate the analytical performance of the recently
developed Access SHBG assay (Beckman Coulter
Inc., Fullerton, CA, USA) on UniCel DxI800 ana-
lyzer and to compare it with another automated
method for SHBG assay: Immulite 2000 (Siemens
Healthcare, Tarrytown, NY, USA). The concor-
dance with the Immunoradiometric assay (IRMA)
Orion Diagnostica was also evaluated in a subset of
samples. The selection of this method is justified on
the basis of its utilization to determine the algo-
rithm for the FT calculation [10]. Moreover, some
clinical findings were obtained.
Material and methods
SHBG levels were assessed by the automated
Access SHBG assay (Beckman Coulter Inc., Fullerton,
CA, USA), a dual-monoclonal chemiluminescent
Scandinavian Journal of Clinical & Laboratory Investigation, 2013; 73: 480–484
ISSN 0036-5513 print/ISSN 1502-7686 online © 2013 Informa Healthcare
DOI: 10.3109/00365513.2013.805807
Scand J Clin Lab Invest Downloaded from informahealthcare.com by Universita Statale Milano on 09/26/14
For personal use only.